Immunology of Infectious Disease News 6.35 September 5, 2018 | |
| |
TOP STORYHuman Monoclonal Antibodies that Neutralize Pandemic GII.4 Noroviruses Researchers studied the antibody-mediated response to the GII.4 strain by isolating monoclonal antibodies (mAbs) to GII.4 from infected patients and developing virus neutralization assays. They used a robust human hybridoma technique to isolate mAbs from patients previously infected with norovirus and identified mAbs that blocked virus binding to cell receptors, using virus-like particles to test blockade ability. [Gastroenterology] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection In a model of severe influenza infection with A/PR8, lack of insulin receptor on T cells curtails antigen-specific immunity to influenza viral antigens. [Cell Metab] Abstract | Press Release | Graphical Abstract Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors The authors discovered that persistent Marburg virus infection of seminiferous tubules, an immune-privileged site that harbors sperm production, is a relatively common event in crab-eating macaques that survived infection after antiviral treatment. [Cell Host Microbe] Abstract | Graphical Abstract PH-797804 had no side effects, did not impact negatively the antiviral immune response and, used alone, had no significant effect on levels of immune activation and did not reduced the viremia. When administered with ART, it significantly reduced numerous immune activation markers compared to ART alone. [PLoS Pathog] Full Article Researchers found that naïve CD4 T cells in chronically hepatitis C virus (HCV)-infected patients were significantly reduced due to apoptosis compared with age-matched healthy subjects. [Cell Death Dis] Full Article Scientists showed that the matrix protein 2 (M2e)-specific IgG2a monoclonal antibody 65 can reduce influenza A/Udorn/72 and A/Hong Kong/68 virus plaque formation. [Antiviral Res] Abstract IL-6 Is Required for Protective Immune Responses against Early Filarial Infection Researchers investigated the role of IL-6 in immune responses to the rodent filarial nematode Litomosoides sigmodontis, a model for human filarial infections. IL-6-/- mice had a significantly increased worm burden after natural infection compared with wild type controls at early time points p.i. [Int J Parasitol] Abstract | Graphical Abstract γδ T Cells Modulate Humoral Immunity against Plasmodium berghei Infection Investigators showed that B cell-immunodeficient mice and γδ T cell-deficient mice were incapable of protecting against P. berghei XAT parasites. [Immunology] Abstract Scientists showed previously that a single immunization with a SIV-based integrase-defective lentiviral vector (IDLV) expressing the 1086.C HIV-1-envelope induced durable, high-magnitude immune responses in non-human primates. They characterized the humoral responses by assessing antibody affinity maturation and antigen-specific memory B-cell persistence in two vaccinated macaques. [Commun Biol] Full Article Subscribe to our sister publications: Human Immunology News & Immune Regulation News. | |
| |
REVIEWSFirst Responders: Innate Immunity to Helminths The authors focus on the innate immune pathways that regulate immunity to helminth parasites and describe how better understanding of these pathways may lead to the development of new therapeutic strategies. [Trends Parasitol] Abstract Investigators summarize recent findings regarding the role of natural killer cells, plasmacytoid dendritic cells, and their cross-talk in HBV infection and its chronicity. [Rev Med Virol] Abstract Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field. | |
| |
SCIENCE NEWSEnanta Pharmaceuticals to Present New Data on Its RSV Inhibitor EDP-938 Enanta Pharmaceuticals, Inc. announced that two abstracts have been accepted for presentation. [Press release from Enanta Pharmaceuticals, Inc. discussing research to be presented at the 11th International Respiratory Syncytial Virus Symposium (RSV), Asheville] Press Release | |
| |
INDUSTRY NEWSInovio Doses 1st Subject in Phase I/II Clinical Trial for Vaccine against Deadly MERS Infection Inovio Pharmaceuticals, Inc. announced announced the dosing of the first subject with its vaccine to prevent infection from the deadly Middle East Respiratory Syndrome (MERS) virus in a Phase I/IIa study to evaluate INO-4700. [Inovio Pharmaceuticals, Inc.] Press Release Altimmune, Inc. announced additional positive data from a Phase IIa study of its NasoVAX intranasal influenza vaccine candidate. [Altimmune, Inc.] Press Release Inovio Pharmaceuticals, Inc. and GeneOne Life Science announced they have dosed the first patient in a Phase I study designed to evaluate a preventive vaccine against hepatitis C infection. [Inovio Pharmaceuticals, Inc.] Press Release | |
| |
POLICY NEWSExperimental Ebola Drugs Face Tough Test in War Zone Health workers fighting the ongoing Ebola outbreak in the Democratic Republic of the Congo have given nearly 20 people experimental drugs to treat the virus since mid-August. But because the drugs have been dispensed on a case-by-case, ‘compassionate use’ basis, it is hard to know whether any are effective. [Nature News] Editorial Trump Science-Adviser Pick Breezes through Senate Committee Vote Meteorologist Kelvin Droegemeier is one step closer to becoming director of the White House Office of Science and Technology Policy and science adviser to President Donald Trump. [Nature News] Editorial Documentary Puts Lens on the Open-Access Movement Upending Scientific Publishing Jason Schmitt was working at Atlantic Records when the online site Napster disrupted the music industry by making copyrighted songs freely available. Now, the communications and media researcher at Clarkson University in Potsdam, New York, is pushing for a similar disruption of academic publishing with Paywall, a documentary about the open-access movement that debuts in a Washington, D.C., theater. [ScienceInsider] Editorial Open-Access Journal Editors Resign after Alleged Pressure to Publish Mediocre Papers All ten senior editors of the open-access journal Nutrients resigned last month, alleging that the publisher, the Multidisciplinary Digital Publishing Institute, pressured them to accept manuscripts of mediocre quality and importance. [ScienceInsider] Editorial European Science Funders Ban Grantees from Publishing in Paywalled Journals Frustrated with the slow transition toward open access in scientific publishing, eleven national funding organizations in Europe turned up the pressure. As of 2020, the group, which jointly spends about €7.6 billion on research annually, will require every paper it funds to be freely available from the moment of publication. [ScienceInsider] Editorial
| |
EVENTSNEW Gordon Research Conference: Tropical Infectious Diseases Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Researcher – Infection Medicine (Karolinska Institutet) NEW Postdoctoral Position – Pneumonia (Justus-Liebig-Universität Gießen) PhD Positions – Infection Biology and Immunology (ZIBI Graduate School Berlin) Postdoctoral Scholar – Hepatitis B Infection (The Pennsylvania State University College of Medicine) Postdoctoral Scientist – Infection and Immunity (Charite – Universitatsmedizin Berlin) PhD Student/Postdoctoral Position – Infection and Cancer Immunology (Heinrich-Heine University) Postdoctoral Fellow – HIV Transmission and Pathogenesis (University of California, San Francisco) Faculty Positions – Infectious Disease Research (Institut Pasteur of Shanghai) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|